MDS experts, Dr Rafael Bejar and Dr Casey O’Connell, provide an overview of how
prognosis (outlook) is determined in MDS. Risk scores are used to predict outlook and decide on treatment options. Your doctor will calculate your
risk score based on which blood counts are low, your number of blasts, and any gene changes they see. They also describe the
International Prognostic Scoring System (IPSS) and the
Revised International Prognostic Scoring System (IPSS-R) tools that categorize risk, ranging from
very low risk to
very high risk. Lastly, the experts explain the various meanings of the term
“risk” as it relates to MDS: risk of the MDS developing into acute myeloid leukemia (AML), as well as risk of overall survival (life expectancy with MDS).
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.